A Study to Evaluate Safety and Efficacy of ALKS 7290 Compared With Placebo in Adult Participants With Attention Deficit Hyperactivity Disorder (ALKS 7290-201)

NCT07755410 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

312

Enrollment

INDUSTRY

Sponsor class

Conditions

Attention Deficit Disorder With Hyperactivity (ADHD)

Interventions

DRUG: ALKS 7290
DRUG: Placebo

Sponsor

Alkermes, Inc.